
TSE:SLF
This summary was created by AI, based on 9 opinions in the last 12 months.
Sun Life Financial Inc. (SLF) has garnered mixed reviews from experts, reflecting a blend of cautious optimism and concerns about its business model transformation. Originally focused on Canadian lifecos, the company has shifted towards mutual fund management, attracting criticism for taking on increased market beta. While some analysts acknowledge positive aspects, such as the potential benefits from rising interest rates and a robust money management division, others express concerns regarding recent challenges in asset management and the entry into private credit markets. Fundamentally, SLF trades at a comparatively lower P/E ratio than Canadian banks, but experts note that the growth rate remains modest. Overall, while the stock has rallied recently, many experts advocate for a cautious approach towards new investments, balancing potential growth against broader economic risks.
They have done really well in Asia over the last 5 years. They have grown it at 30%. He sees good growth there. They have done a great job of getting away from capital heavy businesses into capital light businesses. 12 times earnings, good valuation and a very solid company. (Analysts’ target: $54.00).
He likes this over Manulife (MFC-T), because it is basically flat year-over-year. A good insurance business. Their challenge is their US mutual fund MFF which has had big redemptions, because of everybody going into ETF’s. That seems to have turned now. Expects there will be a dividend increase in 2018 along with better results from MFF. Dividend yield of 3.5%. (Analysts’ price target is $54.)
Buy, Hold or Sell? Doesn't own any insurance companies, as he felt that banks would give him a better rate of return. This pays a nice dividend. He doesn't think rates are going to go up aggressively. They’ve all grown their asset management businesses, and most of them are active, so the passive side has hurt them a great deal. A great company, and could probably be a little more international where there are opportunities.
Generally in rising interest environments, insurance companies do pretty well. He also owns Manulife which has outperformed Sun Life in the last couple years, mainly due to the stumbles in their MFS subsidiary in the US. The situation with MFS should improve now and expects to see Asset Under Management increase. Not too concerned about fees contraction as he thinks this one has been doing a good job controlling costs. Expects to see much better results and growth coming from their Asian activities and a dividend increase soon.
Likes the longer-term outlook, not only for the fact that in a rising rate environment insurance companies tend to benefit, but also in the way they have been able to change their business mix over the years, with an emphasis more on wealth management, pension planning and retirements. They are well positioned in the US. This is a company you can be very comfortable in owning going forward.
All the lifecos will be benefiting from rising interest rates. The amazing thing with this company is that they were never hurt during the financial crisis and never had to cut their dividend. Trading at 11X earnings. Great presence in the US and India. At this valuation with a rising dividend and excess capital, we are undoubtedly going to see increasing share buybacks. Dividend yield of 3.7%. (Analysts’ price target is $52.)
(A Top Pick March 17/17. Up 14%.) He likes insurance companies. In a rising interest rate environment, that’s always a good place to be. He could see this taking a pause, because their US MFS holding represents a good chunk of earnings, and that industry is facing fee pressures and is very dependent on asset growth. Also this is a little less represented in Asia than one of their competitors. Targeting 8%-10% growth in earnings over the next few years. Thinks they could make it, but it could be a bit of a struggle. Consider this to still be a Hold if you own it.